BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35399517)

  • 21. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer.
    Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y
    Front Oncol; 2020; 10():553297. PubMed ID: 33614473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
    World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 26. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.
    Chen G; Song H; Yang Z; Du T; Zheng Y; Lu Z; Zhang K; Wei D
    Front Oncol; 2022; 12():890193. PubMed ID: 35619903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.
    Fang ZX; Hou YY; Wu Z; Wu BX; Deng Y; Wu HT; Liu J
    World J Clin Oncol; 2023 Aug; 14(8):297-310. PubMed ID: 37700807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTO is Associated with Patient Prognosis and Immune Infiltrates in Gastric Cancer and Regulates TGF-β Expression.
    Lai H; Hu N; Zhang M; Jiang W; Han Y; Mao C; Zhou K; Zhang J; Hong Y; Wu F
    Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38879772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
    Huang Z; Yang H; Lao J; Deng W
    PLoS One; 2023; 18(7):e0287303. PubMed ID: 37467193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
    Huo Q; Li Z; Cheng L; Yang F; Xie N
    Front Oncol; 2020; 10():621. PubMed ID: 32528869
    [No Abstract]   [Full Text] [Related]  

  • 32. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
    Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
    World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma.
    Huang Z; Lai H; Liao J; Cai J; Li B; Meng L; Wang W; Mo X; Qin H
    Front Oncol; 2021; 11():729230. PubMed ID: 34604068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53.
    Liao Q; Xiong J
    Exp Ther Med; 2024 Jun; 27(6):255. PubMed ID: 38682111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD.
    Wang Z; Tian Z; Song X; Zhang J
    BMC Immunol; 2022 Jan; 23(1):1. PubMed ID: 34998385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells.
    Ren S; Chen M; Chen Y; Ding K
    Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of cell-extracellular matrix protein Ras suppressor-1 in function and prognosis of gastrointestinal cancers.
    Xu Y; Hou YY; Wu Z; Fang ZX; Wu HT; Liu J
    World J Methodol; 2023 Sep; 13(4):223-237. PubMed ID: 37771863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer.
    Wu A; Zhang S; Liu J; Huang Y; Deng W; Shu G; Yin G
    Front Genet; 2020; 11():705. PubMed ID: 32765584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer.
    Xiang A; Lin X; Xu L; Chen H; Guo J; Zhou F
    Front Mol Biosci; 2020; 7():544895. PubMed ID: 33392251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and immunological role of Fam20C in pan-cancer.
    Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.